Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Massive study to track what happens when AML comes back

NCT ID NCT06459024

Knowledge-focused Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This observational study will follow 4,000 people whose acute myeloid leukemia has returned or not responded to treatment. Researchers will collect data from routine care to understand survival rates and treatment patterns over up to 4 years. No new drugs are being tested; the goal is to learn from real-world experiences.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could reveal which current treatments work best for relapsed/refractory AML, guiding future care decisions.
What could go wrong
This is an observational study, not a treatment trial, so it will not directly test new therapies. Results may be limited by real-world data variability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 4,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2024

Expected to finish

Jul 2032

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with relapsed or refractory acute myeloid leukemia

Ages

6 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with AML diagnosis according to WHO2022 or ICC2022 * Treatment failure (i.e. relapse, refractory or progression, including MRD) according to ELN2022 criteria * Participant or his/her legal representative is willing and able to give informed consent for participation in the study Exclusion Criteria: * Patients included in clinical trials may be enrolled except where otherwise specified in the experimental protocol.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute myeloid leukemia refractory are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute myeloid leukemia refractory Acute myeloid leukemia, in relapse

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    40 sites in 6 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AO Ordine Mauriziano

    RECRUITING

    Torino, TO, 10128, Italy

  • AOU Careggi

    RECRUITING

    Florence, 50019, Italy

  • AOU Città della Salute e della Scienza di Torino

    RECRUITING

    Torino, TO, 10126, Italy

  • AOU Maggiore della Carità

    RECRUITING

    Novara, 28100, Italy

  • AOU San Giovanni di Dio e Ruggi d'Aragona

    RECRUITING

    Salerno, SA, 84131, Italy

  • AOU Universitaria Arcispedale Sant'Anna

    RECRUITING

    Ferrara, FE, 44124, Italy

  • ASST Cremona

    RECRUITING

    Cremona, CR, 26100, Italy

  • ASST Grande Ospedale Metropolitano Niguarda

    RECRUITING

    Milan, MI, 20162, Italy

  • ASST Spedali Civili

    RECRUITING

    Brescia, BS, 25123, Italy

  • ASST Valle Olona

    RECRUITING

    Busto Arsizio, VA, 21052, Italy

  • Azienda Ospedale-Università Padova

    NOT_YET_RECRUITING

    Padova, 35100, Italy

  • Azienda Ospedaliera Ospedali Riuniti Villa Sofia - Cervello

    RECRUITING

    Palermo, PA, 90146, Italy

  • Azienda Ospedaliera S. Croce e Carle

    RECRUITING

    Cuneo, CN, 12100, Italy

  • Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli

    RECRUITING

    Naples, 80131, Italy

  • Azienda Ospedaliero Universitaria Delle Marche

    NOT_YET_RECRUITING

    Ancona, 60126, Italy

  • Azienda Ospeldaliera Universitaria Federico II

    NOT_YET_RECRUITING

    Naples, 80131, Italy

  • Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico

    RECRUITING

    Milan, MI, 20122, Italy

  • Fondazione Policlinico Tor Vergata

    RECRUITING

    Roma, RM, 00133, Italy

  • Fundeni Clinical Institute

    RECRUITING

    Bucharest, 022328, Romania

  • IOV Istituto Oncologico Veneto

    RECRUITING

    Castelfranco Veneto, TV, 31033, Italy

  • IRCCS Ospedale Policlinico San Martino

    RECRUITING

    Genova, GE, 16132, Italy

  • IRST Istituto Romagnolo per lo Studio dei Tumori Dino Amadori

    RECRUITING

    Meldola, 47014, Italy

  • Ospedale "A. Perrino"

    RECRUITING

    Brindisi, BR, 72100, Italy

  • Ospedale San Bortolo

    RECRUITING

    Vicenza, 36100, Italy

  • Ospedale Sant'Andrea

    RECRUITING

    Roma, RM, 00189, Italy

  • Ospedale Santa Maria della Misericordia

    RECRUITING

    Perugia, PG, 06156, Italy

  • Ospedale Santa Maria delle Croci

    RECRUITING

    Ravenna, RA, 48121, Italy

  • Ospedale Valduce

    RECRUITING

    Como, CO, 22100, Italy

  • Ospedale infermi di Rimini

    RECRUITING

    Rimini, RN, 47923, Italy

  • Policlinico Sant'Orsola-Malpighi

    RECRUITING

    Bologna, BO, 40138, Italy

  • Policlinico Umberto I

    RECRUITING

    Roma, RM, 00161, Italy

  • Policlinico Universitario Fondazione Agostino Gemelli

    RECRUITING

    Roma, RM, 00168, Italy

  • Presidio Ospedaliero "Santo Spirito"

    NOT_YET_RECRUITING

    Pescara, PE, 65124, Italy

  • The Hospital of Lithuanian University of Health Sciences Kauno Klinikos

    RECRUITING

    Kaunas, 50161, Lithuania

  • University Clinical Center in Gdańsk

    RECRUITING

    Gdansk, 80-214, Poland

  • University Hospital Aachen

    RECRUITING

    Aachen, 52074, Germany

  • University Hospital Greifswald

    RECRUITING

    Greifswald, 17475, Germany

  • University Hospital Halle

    RECRUITING

    Halle, 06120, Germany

  • University Hospital La Fe

    RECRUITING

    Valencia, 46026, Spain

  • University Hospital of Rostock

    RECRUITING

    Rostock, 18507, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.